Protein prenylation is an essential post-translational
modification
that plays a key role in facilitating protein localization. Aberrations
in protein prenylation have been indicated in multiple disease pathologies
including progeria, some forms of cancer, and Alzheimer’s disease.
While there are single-cell methods to study prenylation, these methods
cannot simultaneously assess prenylation and other cellular changes
in the complex cell environment. Here, we report a novel method to
monitor, at the single-cell level, prenylation and expression of autophagy
markers. An isoprenoid analogue containing a terminal alkyne, substrate
of prenylation enzymes, was metabolically incorporated into cells
in culture. Treatment with a terbium reporter containing an azide
functional group, followed by copper-catalyzed azide–alkyne
cycloaddition, covalently attached terbium ions to prenylated proteins
within cells. In addition, simultaneous treatment with a holmium-containing
analogue of the reporter, without an azide functional group, was used
to correct for non-specific retention at the single-cell level. This
procedure was compatible with other mass cytometric sample preparation
steps that use metal-tagged antibodies. We demonstrate that this method
reports changes in levels of prenylation in competitive and inhibitor
assays, while tracking autophagy molecular markers with metal-tagged
antibodies. The method reported here makes it possible to track prenylation
along with other molecular pathways in single cells of complex systems,
which is essential to elucidate the role of this post-translational
modification in disease, cell response to pharmacological treatments,
and aging.